Novo Nordisk AS
Kurs
Diff. Vortag in %
52 Wochen Tief
52 Wochen Hoch
- Neutral
- Seit dem 24.02.2026
- Informationen von thescreener.com
Tools
Fundamentalanalyse
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 27.02.2026 12 Monate | 27.02.2026 | 12 Monate | 237,90 270 | 237,90 | 270 | 13,493064 | BARCLAYS | ||
| Novo Nordisk AS | 24.02.2026 12 Monate | 24.02.2026 | 12 Monate | 237,90 400 | 237,90 | 400 | 68,137873 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.02.2026 0 Monate | 24.02.2026 | 0 Monate | 237,90 250 | 237,90 | 250 | 5,086171 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 237,90 400 | 237,90 | 400 | 68,137873 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 237,90 332 | 237,90 | 332 | 39,554435 | UBS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 237,90 340 | 237,90 | 340 | 42,917192 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 237,90 275 | 237,90 | 275 | 15,594788 | JEFFERIES | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 237,90 350 | 237,90 | 350 | 47,120639 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 237,90 340 | 237,90 | 340 | 42,917192 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 237,90 275 | 237,90 | 275 | 15,594788 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 237,90 250 | 237,90 | 250 | 5,086171 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 237,90 270 | 237,90 | 270 | 13,493064 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 237,90 340 | 237,90 | 340 | 42,917192 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 237,90 340 | 237,90 | 340 | 42,917192 | BARCLAYS | ||
| Novo Nordisk AS | 17.02.2026 0 Monate | 17.02.2026 | 0 Monate | 237,90 340 | 237,90 | 340 | 42,917192 | BARCLAYS | ||
| Novo Nordisk AS | 12.02.2026 0 Monate | 12.02.2026 | 0 Monate | 237,90 340 | 237,90 | 340 | 42,917192 | BARCLAYS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 237,90 400 | 237,90 | 400 | 68,137873 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 237,90 275 | 237,90 | 275 | 15,594788 | JEFFERIES | ||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 237,90 360 | 237,90 | 360 | 51,324086 | BERENBERG | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 237,90 360 | 237,90 | 360 | 51,324086 | BARCLAYS | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 237,90 360 | 237,90 | 360 | 51,324086 | BARCLAYS | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 237,90 350 | 237,90 | 350 | 47,120639 | JPMORGAN | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 237,90 332 | 237,90 | 332 | 39,554435 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 237,90 475 | 237,90 | 475 | 99,663724 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 237,90 332 | 237,90 | 332 | 39,554435 | UBS | ||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 237,90 350 | 237,90 | 350 | 47,120639 | JPMORGAN | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 237,90 270 | 237,90 | 270 | 13,493064 | JEFFERIES | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 237,90 350 | 237,90 | 350 | 47,120639 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 237,90 350 | 237,90 | 350 | 47,120639 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 237,90 360 | 237,90 | 360 | 51,324086 | BARCLAYS | ||
| Novo Nordisk AS | 01.02.2026 0 Monate | 01.02.2026 | 0 Monate | 237,90 390 | 237,90 | 390 | 63,934426 | UBS | ||
| Novo Nordisk AS | 29.01.2026 0 Monate | 29.01.2026 | 0 Monate | 237,90 350 | 237,90 | 350 | 47,120639 | JPMORGAN | ||
| Novo Nordisk AS | 23.01.2026 12 Monate | 23.01.2026 | 12 Monate | 237,90 270 | 237,90 | 270 | 13,493064 | JEFFERIES | ||
| Novo Nordisk AS | 22.01.2026 12 Monate | 22.01.2026 | 12 Monate | 237,90 436 | 237,90 | 436 | 83,270282 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 22.01.2026 0 Monate | 22.01.2026 | 0 Monate | 237,90 415 | 237,90 | 415 | 74,443043 | BERENBERG | ||
| Novo Nordisk AS | 21.01.2026 12 Monate | 21.01.2026 | 12 Monate | 237,90 360 | 237,90 | 360 | 51,324086 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 20.01.2026 12 Monate | 20.01.2026 | 12 Monate | 237,90 270 | 237,90 | 270 | 13,493064 | JEFFERIES | ||
| Novo Nordisk AS | 20.01.2026 0 Monate | 20.01.2026 | 0 Monate | 237,90 390 | 237,90 | 390 | 63,934426 | UBS | ||
| Novo Nordisk AS | 19.01.2026 0 Monate | 19.01.2026 | 0 Monate | 237,90 390 | 237,90 | 390 | 63,934426 | UBS | ||
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 237,90 360 | 237,90 | 360 | 51,324086 | BARCLAYS | ||
| Novo Nordisk AS | 15.01.2026 0 Monate | 15.01.2026 | 0 Monate | 237,90 415 | 237,90 | 415 | 74,443043 | BERENBERG | ||
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 237,90 475 | 237,90 | 475 | 99,663724 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 237,90 350 | 237,90 | 350 | 47,120639 | JPMORGAN | ||
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 237,90 390 | 237,90 | 390 | 63,934426 | UBS | ||
| Novo Nordisk AS | 09.01.2026 12 Monate | 09.01.2026 | 12 Monate | 237,90 400 | 237,90 | 400 | 68,137873 | BERENBERG | ||
| Novo Nordisk AS | 07.01.2026 12 Monate | 07.01.2026 | 12 Monate | 237,90 400 | 237,90 | 400 | 68,137873 | BERENBERG | ||
| Novo Nordisk AS | 06.01.2026 12 Monate | 06.01.2026 | 12 Monate | 237,90 360 | 237,90 | 360 | 51,324086 | BARCLAYS | ||
| Novo Nordisk AS | 02.01.2026 0 Monate | 02.01.2026 | 0 Monate | 237,90 350 | 237,90 | 350 | 47,120639 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 12 Monate | 12 Monate | 237,90 475 | 237,90 | 475 | 99,663724 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 16.12.2025 12 Monate | 16.12.2025 | 12 Monate | 237,90 350 | 237,90 | 350 | 47,120639 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 237,90 475 | 237,90 | 475 | 99,663724 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 12.12.2025 0 Monate | 12.12.2025 | 0 Monate | 237,90 295 | 237,90 | 295 | 24,001681 | UBS | ||
| Novo Nordisk AS | 11.12.2025 0 Monate | 11.12.2025 | 0 Monate | 237,90 295 | 237,90 | 295 | 24,001681 | UBS | ||
| Novo Nordisk AS | 08.12.2025 12 Monate | 08.12.2025 | 12 Monate | 237,90 350 | 237,90 | 350 | 47,120639 | JPMORGAN | ||
| Novo Nordisk AS | 08.12.2025 12 Monate | 08.12.2025 | 12 Monate | 237,90 352 | 237,90 | 352 | 47,961328 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 04.12.2025 0 Monate | 04.12.2025 | 0 Monate | 237,90 400 | 237,90 | 400 | 68,137873 | BERENBERG | ||
| Novo Nordisk AS | 03.12.2025 0 Monate | 03.12.2025 | 0 Monate | 237,90 295 | 237,90 | 295 | 24,001681 | UBS | ||
| Novo Nordisk AS | 30.11.2025 0 Monate | 30.11.2025 | 0 Monate | 237,90 270 | 237,90 | 270 | 13,493064 | JEFFERIES | ||
| Novo Nordisk AS | 28.11.2025 12 Monate | 28.11.2025 | 12 Monate | 237,90 375 | 237,90 | 375 | 57,629256 | BARCLAYS | ||
| Novo Nordisk AS | 28.11.2025 0 Monate | 28.11.2025 | 0 Monate | 237,90 315 | 237,90 | 315 | 32,408575 | UBS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 12 Monate | 12 Monate | 237,90 475 | 237,90 | 475 | 99,663724 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 26.11.2025 12 Monate | 26.11.2025 | 12 Monate | 237,90 353 | 237,90 | 353 | 48,381673 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 237,90 475 | 237,90 | 475 | 99,663724 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 25.11.2025 0 Monate | 25.11.2025 | 0 Monate | 237,90 500 | 237,90 | 500 | 110,172341 | JPMORGAN | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 237,90 500 | 237,90 | 500 | 110,172341 | JPMORGAN | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 237,90 290 | 237,90 | 290 | 21,899958 | JEFFERIES | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 237,90 375 | 237,90 | 375 | 57,629256 | BARCLAYS | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 237,90 391 | 237,90 | 391 | 64,354771 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.11.2025 0 Monate | 24.11.2025 | 0 Monate | 237,90 | 237,90 | -- | DZ BANK | |||
| Novo Nordisk AS | 17.11.2025 0 Monate | 17.11.2025 | 0 Monate | 237,90 315 | 237,90 | 315 | 32,408575 | UBS | ||
| Novo Nordisk AS | 13.11.2025 0 Monate | 13.11.2025 | 0 Monate | 237,90 400 | 237,90 | 400 | 68,137873 | BERENBERG | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 237,90 475 | 237,90 | 475 | 99,663724 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 10.11.2025 12 Monate | 10.11.2025 | 12 Monate | 237,90 600 | 237,90 | 600 | 152,20681 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 10.11.2025 12 Monate | 10.11.2025 | 12 Monate | 237,90 | 237,90 | -- | DZ BANK | |||
| Novo Nordisk AS | 10.11.2025 0 Monate | 10.11.2025 | 0 Monate | 237,90 315 | 237,90 | 315 | 32,408575 | UBS | ||
| Novo Nordisk AS | 07.11.2025 0 Monate | 07.11.2025 | 0 Monate | 237,90 315 | 237,90 | 315 | 32,408575 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 237,90 600 | 237,90 | 600 | 152,20681 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 237,90 391 | 237,90 | 391 | 64,354771 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.11.2025 0 Monate | 06.11.2025 | 0 Monate | 237,90 540 | 237,90 | 540 | 126,986129 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 237,90 290 | 237,90 | 290 | 21,899958 | JEFFERIES | ||
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 237,90 500 | 237,90 | 500 | 110,172341 | JPMORGAN | ||
| Novo Nordisk AS | 05.11.2025 12 Monate | 05.11.2025 | 12 Monate | 237,90 500 | 237,90 | 500 | 110,172341 | JPMORGAN | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 237,90 290 | 237,90 | 290 | 21,899958 | JEFFERIES | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 237,90 340 | 237,90 | 340 | 42,917192 | UBS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 237,90 540 | 237,90 | 540 | 126,986129 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 237,90 315 | 237,90 | 315 | 32,408575 | UBS | ||
| Novo Nordisk AS | 04.11.2025 0 Monate | 04.11.2025 | 0 Monate | 237,90 540 | 237,90 | 540 | 126,986129 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 237,90 600 | 237,90 | 600 | 152,20681 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 30.10.2025 0 Monate | 30.10.2025 | 0 Monate | 237,90 540 | 237,90 | 540 | 126,986129 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 24.10.2025 0 Monate | 24.10.2025 | 0 Monate | 237,90 290 | 237,90 | 290 | 21,899958 | JEFFERIES | ||
| Novo Nordisk AS | 22.10.2025 12 Monate | 22.10.2025 | 12 Monate | 237,90 600 | 237,90 | 600 | 152,20681 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 21.10.2025 0 Monate | 21.10.2025 | 0 Monate | 237,90 540 | 237,90 | 540 | 126,986129 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 21.10.2025 0 Monate | 21.10.2025 | 0 Monate | 237,90 340 | 237,90 | 340 | 42,917192 | UBS | ||
| Novo Nordisk AS | 20.10.2025 0 Monate | 20.10.2025 | 0 Monate | 237,90 540 | 237,90 | 540 | 126,986129 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 17.10.2025 12 Monate | 17.10.2025 | 12 Monate | 237,90 500 | 237,90 | 500 | 110,172341 | JPMORGAN | ||
| Novo Nordisk AS | 16.10.2025 0 Monate | 16.10.2025 | 0 Monate | 237,90 540 | 237,90 | 540 | 126,986129 | BERNSTEIN RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 10.10.2025 12 Monate | 10.10.2025 | 12 Monate | 237,90 600 | 237,90 | 600 | 152,20681 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 10.10.2025 0 Monate | 10.10.2025 | 0 Monate | 237,90 340 | 237,90 | 340 | 42,917192 | UBS | ||
| Novo Nordisk AS | 09.10.2025 0 Monate | 09.10.2025 | 0 Monate | 237,90 500 | 237,90 | 500 | 110,172341 | JPMORGAN | ||
| Novo Nordisk AS | 06.10.2025 12 Monate | 06.10.2025 | 12 Monate | 237,90 500 | 237,90 | 500 | 110,172341 | JPMORGAN |
News
Aktuell
Novo Nordisk: mehr als nur Abnehmspritzen – die Chance nach dem Kursrutsch?
Der dänische Pharmakonzern Novo Nordisk dominiert mit den Blockbustern Ozempic und Wegovy (Wirkstoff Semaglutid) den milliardenschweren Markt für Diabetes- und Adipositas-Medikamente. Jüngste Gewinnwarnungen, wachsende Konkurrenz (insbesondere durch Eli Lilly) und regulatorische Unsicherheiten (Nachahmerpräparate, Preisdruck) haben die Aktie stark unter Druck gebracht.
DZ BANK Produktauswahl
Discount Classic
Produktauswahl : Basiswert Novo Nordisk AS
Optionsscheine Classic Long
Produktauswahl : Basiswert Novo Nordisk AS
Endlos Turbos Short
Produktauswahl : Basiswert Novo Nordisk AS
Endlos Turbos Long
Produktauswahl : Basiswert Novo Nordisk AS
Mini-Futures Short
Produktauswahl : Basiswert Novo Nordisk AS
Knock Out Map
- wertpapiere@dzbank.de (069) 7447-7035
-
DZ BANK AG, Platz der Republik,
60265 Frankfurt / M